(lp0
S'Celsion Corporation to Hold Year-End 2016 Financial Results Conference Call on ... GlobeNewswire  - Mar 9, 2017 LAWRENCEVILLE, N.J., March 09, 2017  -- Celsion Corporation  announced today that the Company will host a conference call to discuss year-end 2016 financial results and provide an update on its development&nbsp;...Should You Buy Celsion Corporation  On Current Analyst Views? - Fiscal Standard'
p1
aS'Celsion Corporation Announces $5.0 Million Public Offering GlobeNewswire  - Feb 15, 2017 Celsion intends to use the net proceeds from this offering primarily to continue funding development of OPTIMA, its ongoing Phase III clinical trial of ThermoDox in patients with primary liver cancer and OVATION, its ongoing Phase I clinical trial of ...Celsion Corporation  recently purchased by insider Martinez Alberto R Jr - Post AnalystHigh Volume Healthcare Stocks Roundup: Quintiles IMS Holdings, Inc. (Q ... - TWN'
p2
aS'Celsion Corp. Cancer Medications Insider Buying and Analysis Yahoo Finance - Feb 21, 2017 NEW YORK, NY / ACCESSWIRE / February 21, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies, is covering Celsion Corp.  today, in light of recent&nbsp;...'
p3
aS'Is Now The Right Time To Catch The Celsion Corporation  Knife? Insider Financial - Feb 23, 2017 Celsion Corporation  has been a tough stock to hold over the last few years. Following a high profile run up, and subsequent collapse, back in early 2013, the company has basically deteriorated in value almost painfully slowly, and despite&nbsp;...Insider Trading Activity Celsion Corporation   Director Bought ... - Market ExclusiveCelsion Corporation : Analyst Rating Changes and PT Levels - Post Analyst'
p4
aS'Sell-side Weighing in on Celsion Corporation  Whiting Petroleum ... Rives Journal - 19 hours ago Equity Research firms currently have a positive stance on shares of Celsion Corporation . The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.00.'
p5
aS'Celsion prices equity offering; shares slip 35% Seeking Alpha - Feb 15, 2017 Nano cap Celsion  slumps on a 24x surge in volume in response to the pricing of its public offering of ~21.7M shares of common stock at $0.23 per share.'
p6
aS"Today's Brokerage Rating: Celsion Corporation , Inotek Pharmaceuticals ... StockNewsJournal - Mar 14, 2017 Celsion Corporation  have shown a high EPS growth of 31.50% in the last 5 years and has earnings decline of 25.40% yoy.Biotech news that matter for investors: Celsion Corporation (NASDAQ:CLSN ... - The Voice Registrar2 Sizzling Hot Biotechnology Stocks: Celsion Corporation , Inotek ... - The Independent Republic"
p7
aS"What Analysts are Predicting For Amphastar Pharmaceuticals, Inc. (AMPH ... The USA Commerce - 21 hours ago Shares of Amphastar Pharmaceuticals, Inc.  dropped -17.23% to $12.20. During the trading on 03/14/2017, Company's stock ranged from $12.05 to $13.96."
p8
aS"Buy or Sell? What Analysts Recommends: Celsion Corporation , PharmAthene ... StockNewsJournal - Mar 10, 2017 Investors who are keeping close eye on the stock of Celsion Corporation  established that the company was able to keep return on investment at -60.80 in the trailing twelve month while Reuters data showed that industry's average stands at&nbsp;..."
p9
aS'The Technicals For Celsion Corporation  Tell An Interesting Tale NY Stock News - Mar 13, 2017 The technicals for Celsion Corporation  have taken shape, and with them a comprehensive picture has emerged. This is the current state of play as presented by the current technical setup.'
p10
a.